REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 30 filers reported holding REPROS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $19,000 | +171.4% | 28,818 | +38.5% | 0.00% | – |
Q3 2017 | $7,000 | -58.8% | 20,800 | -44.1% | 0.00% | – |
Q2 2017 | $17,000 | -63.0% | 37,200 | -3.4% | 0.00% | – |
Q1 2017 | $46,000 | +35.3% | 38,500 | +48.1% | 0.00% | – |
Q4 2016 | $34,000 | -19.0% | 26,000 | +30.7% | 0.00% | – |
Q3 2016 | $42,000 | +35.5% | 19,900 | -36.9% | 0.00% | – |
Q1 2016 | $31,000 | -66.3% | 31,535 | -58.3% | 0.00% | – |
Q4 2015 | $92,000 | +253.8% | 75,605 | +2419.3% | 0.00% | – |
Q1 2015 | $26,000 | -90.0% | 3,001 | -88.5% | 0.00% | – |
Q4 2014 | $261,000 | -76.9% | 26,186 | -77.1% | 0.00% | -100.0% |
Q3 2014 | $1,131,000 | +883.5% | 114,251 | +1612.1% | 0.00% | – |
Q2 2014 | $115,000 | -61.1% | 6,673 | -60.0% | 0.00% | – |
Q1 2014 | $296,000 | -98.7% | 16,678 | -98.7% | 0.00% | -100.0% |
Q4 2013 | $22,858,000 | -36.2% | 1,249,093 | -6.5% | 0.03% | -44.4% |
Q3 2013 | $35,810,000 | +185.1% | 1,336,206 | +96.3% | 0.05% | +145.5% |
Q2 2013 | $12,562,000 | – | 680,822 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
Renaissance Technologies | 716,413 | $946,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |